O

Obsidian Therapeutics

86 employees

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2015

Funding rounds raised

Total raised

$115M

from 12 investors over 12 rounds

O

Obsidian Therapeutics raised $115M on September 9, 2021

Investors: RA Capital Management, L.P., Logos Global Management, LP, Samsara BioCapital, Vertex Ventures HC, Surveyor Capital, Soleus Capital Management, L.P. and The Column Group

O

Obsidian Therapeutics raised $50M on December 6, 2017

Investors: GV, Takeda UK Limited, Atlas Venture, Vertex Ventures HC and shangpharm

FAQ